Educational and motivational activities increase HPV vaccine uptake with OR 1.57 in adolescents
Educational activities help more teenagers get the HPV vaccine
This randomized trial secondary analysis of 2758 adolescents aged 13 to 15 years found that educational and motivational activities (EMM) we…
New data shows that motivational activities and better information can significantly increase HPV vaccine uptake among teenagers.
Interactive digital assistants may improve short-term HPV vaccine booking and cervical cancer screening uptake
Digital assistants may help people complete cervical cancer screenings
This systematic review of 14 reports evaluated interactive patient-facing digital assistants for HPV vaccination and cervical cancer screeni…
Interactive digital tools like chatbots and health apps can help more people book HPV vaccine appointments and complete cervical cancer scre…
Papilloguard with AS04 shows non-inferior immunogenicity to Gardasil in HPV vaccine trial
Trial Shows Papilloguard Vaccine Provides Strong Protection Against HPV Infection
This Phase III RCT in 670 healthy individuals aged 15-25 years found that Papilloguard (quadrivalent HPV vaccine with AS04) was non-inferior…
A new trial shows the Papilloguard vaccine provides strong antibody levels against four types of HPV, similar to current standard treatments…
Three-dose HPV vaccine regimens provide highest seroconversion rates and protection against persistent infection
Three Dose HPV Vaccine Shows Highest Protection Against Infection
This network meta-analysis evaluates different HPV vaccine dose schedules (1D, 2D, and 3D) for females aged 9 to 26 years. The study finds t…
A review of vaccine data shows that a three-dose schedule provides the highest protection against certain HPV infections for girls and young…
HPV vaccination reduces infection and viral persistence but shows variable results for high-grade lesions
HPV Vaccines Show Links to Reduced Infection and Viral Persistence
This narrative review examines the effectiveness of HPV vaccination in preventing human papillomavirus infections, viral dynamics, and relat…
New evidence suggests HPV vaccines may help reduce viral persistence and infection rates in adults aged 18 to 45.
Systematic review and meta-analysis of HPV vaccine awareness and uptake in Cameroon
Only 22.9 percent of Cameroon participants received the HPV vaccine despite high awareness among doctors
This systematic review and meta-analysis synthesizes data from 33 studies involving 8,175 participants in Cameroon regarding HPV vaccine awa…
In Cameroon, only 22.9 percent of people got the HPV vaccine. While doctors recommend it, knowledge gaps and changing attitudes are blocking…